Back to search
EBV-DNA Viremia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which EBV-DNA Viremia trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which EBV-DNA Viremia trials you may qualify forThis exploratory clinical study focuses on the use of EBV-AST cell infusion for treating EBV-DNA viremia following allogeneic hematopoietic stem cell transplant…
Opportunistic CMV viremia (primary infection or reactivation) is usually managed by taking prophylactic medication for both adult and pediatric kidney transplan…
Transplant recipients are treated with immunosuppressive drugs to avoid rejection of the transplanted organ. As the medication impairs the immune response, it a…
This is a multicenter, open-label, single-arm Phase 1B/2 study to assess the safety and efficacy of tabelecleucel in combination with pembrolizumab for the trea…